Clinical Trials Browser

Adenocarcinoma × SS1(dsFv)PE38 × Thoracic × Clear all

NCT01051934 2017-07-02

A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma

Phase 1 Completed

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms